Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
2.43
Dollar change
-0.08
Percentage change
-3.19
%
Index- P/E- EPS (ttm)-0.97 Insider Own52.63% Shs Outstand17.05M Perf Week-14.44%
Market Cap42.25M Forward P/E- EPS next Y-0.83 Insider Trans0.44% Shs Float8.24M Perf Month-15.33%
Income-17.31M PEG- EPS next Q-0.29 Inst Own36.38% Short Float0.28% Perf Quarter19.12%
Sales56.66M P/S0.75 EPS this Y28.44% Inst Trans2.50% Short Ratio0.45 Perf Half Y75.45%
Book/sh1.01 P/B2.40 EPS next Y13.02% ROA-30.51% Short Interest0.02M Perf Year42.11%
Cash/sh1.41 P/C1.73 EPS next 5Y- ROE-69.97% 52W Range1.30 - 3.71 Perf YTD22.11%
Dividend Est.- P/FCF- EPS past 5Y2.69% ROI-43.68% 52W High-34.50% Beta1.33
Dividend TTM- Quick Ratio4.01 Sales past 5Y10.63% Gross Margin59.13% 52W Low86.88% ATR (14)0.17
Dividend Ex-Date- Current Ratio4.32 EPS Y/Y TTM52.30% Oper. Margin-27.90% RSI (14)35.00 Volatility6.27% 5.98%
Employees179 Debt/Eq1.36 Sales Y/Y TTM7.05% Profit Margin-30.56% Recom1.33 Target Price6.25
Option/ShortYes / Yes LT Debt/Eq1.25 EPS Q/Q42.51% Payout- Rel Volume0.40 Prev Close2.51
Sales Surprise14.76% EPS Surprise52.94% Sales Q/Q6.56% EarningsAug 05 BMO Avg Volume52.40K Price2.43
SMA20-11.00% SMA50-16.02% SMA20012.45% Trades Volume20,710 Change-3.19%
Date Action Analyst Rating Change Price Target Change
Aug-05-22Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-15-21Resumed Cowen Outperform $26
Apr-15-21Initiated Canaccord Genuity Buy $25
Nov-10-20Initiated KeyBanc Capital Markets Overweight $32
Oct-08-20Initiated BTIG Research Buy $18
Jun-02-20Resumed Cantor Fitzgerald Overweight $19 → $20
Oct-14-19Initiated William Blair Outperform
Oct-14-19Initiated Cowen Outperform $17
Oct-14-19Initiated Cantor Fitzgerald Overweight $18
Oct-29-24 04:05PM
Oct-21-24 04:05PM
Sep-04-24 04:05PM
Aug-29-24 09:55AM
Aug-26-24 08:50AM
09:15AM Loading…
Aug-09-24 09:15AM
Aug-08-24 08:50AM
Aug-05-24 12:53PM
09:10AM
08:00AM
Aug-02-24 09:00AM
Aug-01-24 09:00AM
Jul-22-24 09:00AM
Jun-13-24 08:50AM
May-15-24 05:01AM
12:53PM Loading…
May-13-24 12:53PM
09:10AM
08:00AM
May-06-24 04:05PM
Apr-30-24 04:05PM
Apr-26-24 08:30AM
Mar-19-24 09:37AM
01:55AM
Mar-18-24 12:52PM
09:25AM
08:00AM
Mar-08-24 09:00AM
Mar-07-24 04:05PM
Feb-06-24 08:50AM
Jan-30-24 04:05PM
12:00PM Loading…
Jan-07-24 12:00PM
Nov-13-23 04:05PM
Nov-09-23 04:05PM
Nov-02-23 04:05PM
Oct-30-23 04:05PM
Sep-28-23 04:05PM
Sep-12-23 04:05PM
Aug-09-23 10:47AM
Aug-08-23 04:13AM
Aug-07-23 09:15AM
08:00AM
Jul-26-23 04:05PM
Jul-25-23 04:05PM
Jul-24-23 04:05PM
07:33AM
Jun-13-23 08:19AM
May-30-23 09:00AM
May-17-23 07:11AM
May-16-23 11:03AM
May-15-23 05:55PM
04:05PM
May-01-23 04:05PM
Apr-24-23 04:05PM
Mar-24-23 08:16AM
Mar-22-23 06:12AM
Mar-21-23 07:40AM
Mar-20-23 05:25PM
04:05PM
Mar-06-23 04:05PM
Feb-27-23 09:00AM
Feb-14-23 06:19AM
Jan-30-23 04:05PM
Jan-23-23 09:00AM
Nov-14-22 07:55PM
04:05PM
Nov-08-22 04:05PM
Oct-31-22 04:05PM
Oct-17-22 09:00AM
Oct-04-22 08:25AM
Sep-20-22 04:05PM
Sep-19-22 10:20AM
Sep-01-22 04:05PM
Aug-05-22 12:00PM
Aug-04-22 06:55PM
04:06PM
04:05PM
Jul-25-22 04:05PM
Jul-21-22 04:05PM
Jul-05-22 08:25AM
Jun-21-22 08:10AM
Jun-09-22 08:25AM
May-26-22 04:05PM
May-16-22 04:05PM
May-11-22 05:55PM
04:06PM
04:05PM
May-10-22 10:45AM
May-03-22 05:15PM
May-01-22 12:00PM
Apr-25-22 04:05PM
Apr-20-22 04:05PM
Apr-12-22 07:22AM
Mar-30-22 08:25AM
Mar-22-22 10:00PM
05:25PM
04:06PM
04:05PM
Mar-16-22 04:05PM
Mar-09-22 05:35PM
04:05PM
Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adawi KamalOfficerOct 08 '24Proposed Sale2.9484,162247,436Oct 08 04:39 PM
Adawi KamalOfficerAug 09 '24Proposed Sale2.7652,624145,242Aug 09 05:08 PM
ABALLI JOHNPresident and CEOMay 16 '24Buy1.9240,40177,57040,401May 16 08:02 PM
Adawi KamalCFO and Corporate SecretaryMar 04 '24Sale1.9112,78424,407243,749Mar 06 04:05 PM
Adawi KamalCFO and Corporate SecretaryFeb 06 '24Sale1.956,73813,133181,533Feb 08 04:05 PM